Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€142.86
08.07.21
€177.00
08.07.22
22.71%
08.07.22

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€86.85
08.07.21
€115.00
08.07.22
13.32%
08.07.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€72.75
08.07.21
€105.00
08.07.22
36.34%
15.11.21

buy
Roche Holding AG

Start price
Target price
Perf. (%)
€246.00
08.07.21
-
08.07.22
-
06.08.21

buy
Novartis AG

Start price
Target price
Perf. (%)
€80.00
08.07.21
-
08.07.22
-
06.08.21

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€12.28
07.07.21
€18.00
07.07.22
11.20%
13.07.21

buy
Bayer AG

Start price
Target price
Perf. (%)
€50.85
06.07.21
-
06.07.22
-8.03%
10.08.21

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€66.18
05.07.21
€76.00
05.07.22
-5.42%
11.09.21

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.10
05.07.21
-
05.07.22
31.62%
12.07.21

Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.10
04.07.21
-
04.07.22
6.62%
26.07.21

buy
Corbus Pharmaceuticals Holding Inc.

Start price
Target price
Perf. (%)
€44.45
03.07.21
-
03.07.22
-83.45%
10.05.22

buy
Medigene AG

Start price
Target price
Perf. (%)
€3.90
02.07.21
-
02.07.22
-20.90%
09.03.22

Innovative
Dependend from some customers or products
Higher risks for its business
buy
Enwave Corporation

Start price
Target price
Perf. (%)
€0.71
01.07.21
€1.10
01.07.22
-35.41%
02.07.22

buy
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€13.06
30.06.21
€16.00
30.06.22
-39.28%
09.07.21

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
buy
Evotec SE

Start price
Target price
Perf. (%)
€38.53
30.06.21
-
30.06.22
-33.25%
27.05.22

buy
Ocuphire Pharma Inc.

Start price
Target price
Perf. (%)
€5.00
30.06.21
€8.00
30.06.22
-22.40%
09.07.21

Could be worthwhile Investment >10% per year
Good culture
Little innovation
buy
Geron Corp.

Start price
Target price
Perf. (%)
€1.20
29.06.21
-
29.06.22
-9.92%
24.07.21

Probably not worthwhile Investment
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€109.05
28.06.21
€150.00
28.06.22
-55.31%
29.06.22

Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€51.63
28.06.21
€58.00
18.01.23
10.09%
18.01.23

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Biogen Inc.

Start price
Target price
Perf. (%)
€282.65
28.06.21
€240.00
28.06.22
-31.92%
29.06.22

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€94.40
28.06.21
-
28.06.22
-48.38%
29.06.22

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.23
28.06.21
-
28.06.22
-24.89%
29.06.22

buy
Pra Health

Start price
Target price
Perf. (%)
€141.00
28.06.21
€200.00
28.06.22
-0.71%
12.07.21

Could be worthwhile Investment >10% per year
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€72.60
28.06.21
€120.00
28.06.22
-21.07%
12.07.21

Could be worthwhile Investment >10% per year